Benzinga | Jun 18, 2021 08:08AM EDT

Argus Research Maintains Buy on Bio-Techne, Raises Price Target to $490

Argus Research analyst David Toung maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $440 to $490.